TravoTim-Vision

TravoTim-Vision is a medicine authorised by Swissmedic under authorisation number 67232. The authorisation holder is OmniVision AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 April 2020 and the authorisation is valid without a time limit. ATC code S01ED51 places the medicine in the group Ophthalmologicals.

Dispensing category B
Authorisation number 67232
ATC S01ED51
Synthetic medicines

Authorisation data
Authorisation number	67232
Name	TravoTim-Vision
Full name	TravoTim-Vision, Augentropfen
Authorisation holder	OmniVision AG
Medicinal product code	Synthetic medicines
Dispensing category	B · Prescription only
ATC code	S01ED51
First authorisation	24 April 2020
Authorisation validity	unlimited

Strengths
No.	Name	Dispensing category	Authorisation date
1	TravoTim-Vision, Augentropfen	B	24 April 2020

Scroll the table sideways

Pack sizes
Pack code	Quantity	Unit	ATC	IT code	Dispensing category
1	2,5	ml	S01ED51	11.09.0.	B
2	3 x 2,5	ml	S01ED51	11.09.0.	B

Scroll the table sideways

Medicines in the same ATC group

AzargaAuthorisation number 59179 · Novartis Pharma Schweiz AG · ATC S01ED51B BimatoTim-Vision SDU 0Authorisation number 70220 · OmniVision AG · ATC S01ED51B Bimatoprost-Mepha PlusAuthorisation number 66976 · Mepha Pharma AG · ATC S01ED51B Co-Latanoprost ViatrisAuthorisation number 61849 · Viatris Pharma GmbH · ATC S01ED51B CombiganAuthorisation number 56947 · AbbVie AG · ATC S01ED51B CosoptAuthorisation number 54624 · Santen SA · ATC S01ED51B Cosopt-SAuthorisation number 57707 · Santen SA · ATC S01ED51B DorzoComp-Vision 20mg/ml / 5mg/mlAuthorisation number 65629 · OmniVision AG · ATC S01ED51B DorzoComp-Vision SDU 20 mg/ml + 5mg/mlAuthorisation number 69149 · OmniVision AG · ATC S01ED51B Duelym 0.1 mg/g (bimatoprost) + 1mg/g (timolol)Authorisation number 69856 · THEA Pharma S.A. · ATC S01ED51B DuokoptAuthorisation number 66001 · THEA Pharma S.A. · ATC S01ED51B DuotravAuthorisation number 57615 · Novartis Pharma Schweiz AG · ATC S01ED51B

Other medicines from this authorisation holder

AciVision 30 mg/gAuthorisation number 68800 · ATC S01AD03A Aflivis 40 mg/mlAuthorisation number 70061 · ATC S01LA05B Aflivis 40 mg/mlAuthorisation number 70062 · ATC S01LA05B Allergo-Vision SDU 0.25 mg/mlAuthorisation number 68345B BimatoTim-Vision SDU 0Authorisation number 70220 · ATC S01ED51B Brimo-Vision 2 mg/mlAuthorisation number 67312 · ATC S01EA05B Brinzo-Vision 10 mg/mlAuthorisation number 70749 · ATC S01EC04B Dorzo-Vision 2 %Authorisation number 62671 · ATC S01EC03B

Frequently asked questions

Is TravoTim-Vision authorised in Switzerland?

Yes. TravoTim-Vision is authorised by Swissmedic under authorisation number 67232, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does TravoTim-Vision have?

TravoTim-Vision is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of TravoTim-Vision?

The authorisation holder is OmniVision AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.